Further studies on the site of action of nicotinic blocking drugs.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002645:Chickens; D002794:Choline / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004491:Edrophonium / Q000494:pharmacology; D004558:Electric Stimulation; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D009132:Muscles / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D000644:Quaternary Ammonium Compounds; D004491:Edrophonium; D010830:Physostigmine; D002794:Choline; D000109:Acetylcholine; D014403:Tubocurarine